Our Pricing

Understanding Saxenda Doses: Complete UK Dosing Guide

Understanding saxenda doses is essential for safe and effective weight management, as this GLP-1 medication requires careful dose escalation over five weeks to minimise side effects whilst optimising results. Saxenda (liraglutide 3mg) follows a structured dosing protocol approved by the MHRA, starting at 0.6mg daily and gradually increasing to the maintenance dose of 3mg. At Cured Pharmacy, our UK-registered clinical team provides comprehensive dosing guidance alongside competitive pricing, ensuring you receive expert support throughout your weight loss journey.

Saxenda Doses: The Five-Week Escalation Protocol

The saxenda doses protocol is designed as a gradual five-week escalation to help your body adapt to liraglutide whilst minimising gastrointestinal side effects. This structured approach, validated in the SCALE clinical trial programme, begins at 0.6mg daily for week one, then increases by 0.6mg increments each subsequent week until reaching the maintenance dose of 3mg daily by week five [1]. This titration schedule is not optional—it represents the evidence-based standard recommended by the MHRA and endorsed by NICE guidance.

Each saxenda dose increase should occur at seven-day intervals, allowing sufficient time for your body to adjust to the higher liraglutide concentration. Clinical data demonstrates that patients who follow this gradual escalation experience significantly fewer discontinuations due to nausea and other gastrointestinal symptoms compared to those attempting faster dose increases [2]. Our clinical team at Cured Pharmacy provides detailed written instructions with each prescription, ensuring you understand exactly when and how to adjust your daily injection throughout the titration period.

The specific saxenda doses schedule is: Week 1 at 0.6mg, Week 2 at 1.2mg, Week 3 at 1.8mg, Week 4 at 2.4mg, and Week 5 onwards at the full 3mg maintenance dose. If you experience persistent nausea or vomiting at any stage, our prescribers may recommend staying at your current dose for an additional week before progressing, though the goal remains reaching 3mg daily for optimal weight loss efficacy. Subject to prescriber approval, this flexible approach balances tolerability with therapeutic outcomes.

Starting Saxenda Doses: What to Expect in Week One

Your initial saxenda dose of 0.6mg daily serves as an introductory phase, allowing your body to begin adapting to GLP-1 receptor stimulation with minimal risk of significant side effects. At this low starting dose, you may notice mild appetite suppression, though substantial weight loss is uncommon during the first week—the primary objective is establishing injection technique and assessing initial tolerability [3]. Each Saxenda pen is pre-filled with 6mg/ml liraglutide solution, and the pen dial allows precise dose selection from 0.6mg upwards.

During this first week on saxenda doses, our clinical team recommends injecting at the same time each day to establish routine and maintain consistent liraglutide levels. The injection can be administered subcutaneously in the abdomen, thigh, or upper arm, and you should rotate injection sites to prevent lipodystrophy. Common experiences at the 0.6mg starting dose include slight nausea (typically mild and transient), occasional headache, and reduced hunger between meals—all indicators that the medication is beginning to work on GLP-1 receptors in your gut and brain.

If you miss a saxenda dose during week one or any subsequent week, the manufacturer guidance advises taking it as soon as you remember if within 12 hours of your usual time; otherwise, skip that dose and resume your normal schedule the following day. Never double up on saxenda doses to compensate for a missed injection, as this significantly increases the risk of nausea and vomiting. Our pharmacists at Cured Pharmacy are available on (+44) 116 4646009 to answer any questions about missed doses or injection technique during your first week.

Week One Injection Technique for Saxenda Doses

Proper injection technique is crucial when administering saxenda doses, particularly as you begin treatment. Remove the pen from refrigeration 15 minutes before injection to allow the solution to reach room temperature, which reduces injection site discomfort. Attach a new needle for each injection, select 0.6mg on the dose counter, pinch a fold of skin at your chosen site, insert the needle at 90 degrees, press the dose button fully, and hold for six seconds before withdrawing to ensure complete dose delivery [4]. Our patient information leaflet includes illustrated step-by-step guidance, and our clinical team can provide additional support if you're uncertain about any aspect of the injection process.

Saxenda Doses Weeks 2-4: The Escalation Phase

The middle weeks of saxenda doses escalation—progressing from 1.2mg through 1.8mg to 2.4mg—represent the period where most patients begin experiencing meaningful appetite suppression and initial weight loss. Each weekly increase of 0.6mg builds upon the previous week's adaptation, with clinical trial data showing average weight loss of 2-3kg by the end of week four in adherent patients [1]. This gradual approach allows your gastrointestinal system to adjust to higher liraglutide concentrations whilst maintaining tolerability.

At the 1.8mg and 2.4mg saxenda doses, you'll likely notice more pronounced effects on satiety, with many patients reporting significantly reduced portion sizes and decreased cravings for high-calorie foods. These doses approach the therapeutic range where liraglutide's dual action—slowing gastric emptying and signalling satiety to the hypothalamus—becomes clinically significant for weight management. However, this is also the phase where side effects, if they occur, tend to be most noticeable, particularly nausea, constipation, or occasional diarrhoea.

Our prescribers at Cured Pharmacy may recommend staying at a particular saxenda dose for an additional week if you experience persistent gastrointestinal symptoms during escalation. This individualised approach, whilst extending the titration period slightly, often improves long-term adherence by preventing treatment discontinuation due to intolerable side effects. The goal remains reaching the full 3mg maintenance dose, as clinical trials demonstrate superior weight loss outcomes at this level compared to sub-therapeutic dosing [2].

Managing Side Effects During Saxenda Doses Escalation

Nausea is the most commonly reported side effect during saxenda doses escalation, affecting approximately 40% of patients in clinical trials, though typically mild and transient [3]. To minimise gastrointestinal symptoms, eat smaller, more frequent meals rather than large portions, avoid high-fat foods which slow digestion further, stay well-hydrated, and consider taking your injection in the evening if daytime nausea is problematic. If symptoms persist beyond a few days at any dose level, contact our clinical team for guidance—continuing to escalate despite severe nausea often leads to treatment discontinuation, whereas a temporary pause usually allows successful progression.

Saxenda Doses: The 3mg Maintenance Phase

Reaching the full 3mg saxenda dose by week five marks the beginning of your maintenance phase, where the medication exerts its maximum therapeutic effect for weight management. Clinical trial data from the SCALE programme demonstrated that patients maintaining the 3mg daily dose achieved average weight loss of 8-9% of initial body weight over 56 weeks, compared to 2.6% with placebo [1]. This maintenance dose should be continued long-term, as discontinuation typically results in weight regain—liraglutide is not a short-term intervention but rather an ongoing component of comprehensive weight management.

At the 3mg saxenda dose, you should experience sustained appetite suppression, reduced hunger between meals, earlier satiety when eating, and decreased preoccupation with food. These effects support the behavioural and dietary modifications essential for successful weight loss, making it easier to maintain a calorie deficit without the intense hunger that often undermines traditional dieting. Our clinical team recommends combining your daily injection with a reduced-calorie diet and increased physical activity, as this multimodal approach produces superior outcomes to medication alone.

Each Saxenda pen contains sufficient solution for approximately six days at the 3mg maintenance saxenda dose, meaning you'll typically use five pens per month. At Cured Pharmacy, we supply Saxenda from £48.00 per pen, with your first order eligible for £20 off using code Weightlossnew, reducing your initial cost to £48.00. All prescriptions require clinical assessment by our UK-registered prescribers, ensuring Saxenda is appropriate for your individual circumstances and that you receive proper dosing guidance and ongoing monitoring throughout treatment.

Adjusting Saxenda Doses: When and Why

Whilst the standard saxenda doses protocol targets 3mg daily maintenance, some patients may require dose adjustments based on tolerability or clinical response. If you experience persistent, intolerable side effects at 3mg despite dietary modifications and symptom management strategies, your prescriber may recommend reducing to 2.4mg temporarily, though this lower dose may provide less robust weight loss [4]. Conversely, if you reach 3mg but fail to achieve at least 5% weight loss after 12 weeks at the maintenance dose, NICE guidance suggests discontinuing Saxenda, as further treatment is unlikely to produce clinically meaningful results.

Certain clinical situations warrant temporary saxenda dose reductions or treatment interruption. Acute illness causing vomiting or diarrhoea may necessitate pausing injections until you've recovered, as the combination of illness-related fluid loss and Saxenda's effects on gastric emptying could increase dehydration risk. Similarly, if you're scheduled for surgery requiring general anaesthesia, your surgical team may advise stopping Saxenda several days beforehand due to its gastric emptying effects. Our clinical team provides clear written guidance on managing these scenarios and safely resuming your normal saxenda dose afterwards.

Never adjust your saxenda doses without consulting a healthcare professional, as both under-dosing and over-dosing carry risks. Sub-therapeutic doses may fail to produce meaningful weight loss, potentially leading to unnecessary medication costs without clinical benefit, whilst exceeding the recommended 3mg daily maximum increases side effect risk without additional efficacy. If you have concerns about your current dose or treatment response, our prescribers at Cured Pharmacy are available for medication reviews and can adjust your prescription as clinically appropriate, subject to ongoing assessment of your individual circumstances.

Saxenda Doses in Special Populations

Certain patient groups require additional consideration when prescribing saxenda doses. Patients with renal impairment can typically use standard dosing without adjustment, as liraglutide is primarily metabolised by protein degradation rather than renal excretion, though those with severe renal impairment warrant closer monitoring [2]. Patients over 65 years may experience slightly higher rates of gastrointestinal side effects, potentially benefiting from a more gradual escalation schedule. Saxenda is not licensed for use in patients under 18 years or during pregnancy and breastfeeding, and our prescribers will assess these factors during your clinical consultation to ensure safe, appropriate treatment.

Saxenda Doses: Long-Term Management and Monitoring

Successful long-term weight management with saxenda doses requires ongoing clinical monitoring and regular prescriber reviews. Our clinical team recommends weight and BMI measurements at baseline, 12 weeks, and then every 3-6 months during continued treatment to assess response and guide treatment decisions. If you achieve your target weight loss, continuing the 3mg maintenance saxenda dose helps prevent weight regain—clinical trials demonstrate that patients who discontinue liraglutide typically regain two-thirds of lost weight within one year [3]. This underscores Saxenda's role as a long-term weight management tool rather than a temporary intervention.

Throughout your treatment with saxenda doses, our prescribers monitor for potential adverse effects and contraindications that may develop. We assess for symptoms of pancreatitis (severe, persistent abdominal pain), gallbladder disease (right upper quadrant pain, particularly after meals), and changes in heart rate, as liraglutide can cause modest increases in resting pulse. Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use Saxenda due to theoretical thyroid C-cell tumour risk identified in rodent studies, though no causal relationship has been established in humans [4].

At Cured Pharmacy, we provide ongoing prescriber access throughout your saxenda doses journey, ensuring you receive continuous clinical support as your treatment progresses. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all weight loss prescriptions, and our UK-registered clinical team remains available for medication reviews, side effect management, and dosing guidance. We supply only genuine UK-licensed Saxenda at competitive pricing, with transparent costs displayed before your consultation and discreet packaging for all deliveries. To begin your clinical assessment for Saxenda, complete our online consultation, which takes under three minutes and is reviewed by our prescribers within hours.

Scientific References

1. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22.
2. Wadden, T. A., Hollander, P., Klein, S., Niswender, K., Woo, V., Hale, P. M., & Aronne, L. (2013). Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. International Journal of Obesity, 37(11), 1443-1451.
3. Astrup, A., Carraro, R., Finer, N., Harper, A., Kunesova, M., Lean, M. E., ... & Salas-Salvadó, J. (2012). Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. International Journal of Obesity, 36(6), 843-854.
4. Novo Nordisk. (2023). Saxenda (liraglutide) Summary of Product Characteristics. Electronic Medicines Compendium.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.